Thermosensitive Liposomal Codelivery of HSA–Paclitaxel and HSA–Ellagic Acid Complexes for Enhanced Drug Perfusion and Efficacy Against Pancreatic Cancer-Reference-Cited by-同舟云学术

Thermosensitive Liposomal Codelivery of HSA–Paclitaxel and HSA–Ellagic Acid Complexes for Enhanced Drug Perfusion and Efficacy Against Pancreatic Cancer

Published:2017-07-24 Issue:30 Volume:9 Page:25138-25151
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Wei Yan¹,Wang Yuxi¹²,Xia Dengning¹,Guo Shiyan¹,Wang Feng³,Zhang Xinxin¹,Gan Yong¹^ORCID

Affiliation:

1. Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Haike Road, Shanghai 201203, China

2. Nano Science and Technology Institute, University of Science and Technology of China, 166 Renai Road, Suzhou, Jiangsu 215123, China

3. Shanghai Institute of Pharmaceutical Industry, 285 Gebaini Road, Shanghai 201203, China

Funder

China Postdoctoral Science Foundation

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.7b07132

Reference64 articles.

1. Tumor-stroma interactions in pancreatic ductal adenocarcinoma

2. Pancreatic Cancer—Could It Be that Simple? A Different Context of Vulnerability

3. New avenues for improving pancreatic ductal adenocarcinoma (PDAC) treatment: Selective stroma depletion combined with nano drug delivery

4. Mucins in pancreatic cancer and its microenvironment

5. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FAP-activated liposomes achieved specific macropinocytosis uptake by pancreatic stellate cells for efficient desmoplasia reversal;Chemical Engineering Journal;2024-09

2. Exploring the underlying pharmacological, immunomodulatory, and anti-inflammatory mechanisms of phytochemicals against wounds: a molecular insight;Inflammopharmacology;2024-08-13

3. Enzyme-responsive liposomes for controlled drug release;Drug Discovery Today;2024-07

4. Lipid nanovehicles overcome barriers to systemic RNA delivery: Lipid components, fabrication methods, and rational design;Acta Pharmaceutica Sinica B;2024-02

5. GP60 and SPARC as albumin receptors: key targeted sites for the delivery of antitumor drugs;Frontiers in Pharmacology;2024-01-23